Jim Simons’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$372K Buy
+60,400
New +$502K ﹤0.01% 2726
2025
Q4
Sell
-138,700
Closed -$1.25M 3684
2025
Q3
$1.25M Sell
138,700
-287,700
-67% -$2.53M ﹤0.01% 2374
2025
Q2
$5.54M Sell
426,400
-25,200
-6% -$379K 0.01% 1461
2025
Q1
$11.4M Buy
451,600
+90,100
+25% +$2.68M 0.02% 943
2024
Q4
$12.4M Buy
361,500
+183,300
+103% +$8.27M 0.02% 886
2024
Q3
$8.81M Sell
178,200
-51,900
-23% -$2.66M 0.01% 1106
2024
Q2
$13.8M Buy
230,100
+73,100
+47% +$4.18M 0.02% 760
2024
Q1
$8.1M Buy
+157,000
New +$7.71M 0.01% 1111
2023
Q3
Sell
-38,900
Closed -$1.12M 4042
2023
Q2
$1.12M Buy
38,900
+24,600
+172% +$547K ﹤0.01% 2402
2023
Q1
$239K Buy
+14,300
New +$202K ﹤0.01% 3206

Other funds holding RXST

Jim Simons's RXST Position: Q1 2026 in Review

Jim Simons opened a new position in RxSight (RXST) in Q1 2026: 60,400 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #2726 among its holdings. This is a return to the name: Jim Simons previously reported a position in RXST as recently as Q3 2025.

Jim Simons first reported a position in RXST in Q1 2023 and has held it in 10 quarters since. The position peaked at $13.8M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Jim Simons held 60,400 shares of RxSight worth $372K as of Q1 2026.
  • RxSight was a new Jim Simons position in Q1 2026.
  • RxSight made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2726 holding.
  • Jim Simons first reported a position in RxSight in Q1 2023 and has held it in 10 quarters since.
  • Jim Simons's RxSight position peaked at $13.8M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.